Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Baker Bros. Advisors Lp Insider Profile
130 Followers
Baker Bros. Advisors Lp, Ten Percent Owner at BioCryst, holds 3.76M shares in IGM Biosciences (Ticker: IGMS), holds 34.04M shares in Incyte (Ticker: INCY), holds 89.25K shares in vTv Therapeutics (Ticker: VTVT).
Baker Bros. Advisors Lp BioCryst (BCRX)Ten Percent Owner
BioCryst (BCRX)
Ten Percent Owner
Ranked #201 out of 98,501 Corporate Insiders
Profitable Transactions
52 out of 93 Profitable Transactions
Average Return
+29.10%
Average return per transaction
Time Frame
Compare to
Insider Holdings
A breakdown of Baker Bros. Advisors Lp's holdings
Insider Roles
Roles that Baker Bros. Advisors Lp holds in companies
Most Profitable Insider Trade
The most profitable trade made by Baker Bros. Advisors Lp
Baker Bros. Advisors Lp's Trading History
BioCryst
Aug 16, 2016
Ten Percent Owner
Informative Sell
20.25M
$68.99M
Bellicum Pharmaceuticals
Nov 24, 2023
―
Uninformative Buy
―
$160.49K
BeiGene
Nov 14, 2023
Director, Ten Percent Owner
Informative Sell
198.55M
$1.31B
Aceragen
Jul 03, 2019
―
Uninformative Buy
15.47K
$1.65M
Alexion Pharmaceuticals
May 18, 2020
―
Uninformative Buy
―
$1.47B
Kiniksa Pharmaceuticals
Jun 08, 2023
Director
Uninformative Buy
―
$46.60M
Hookipa Pharma
Apr 23, 2019
Former 10% owner
Informative Buy
12.50M
$625.40K
Kodiak Sciences
Jun 06, 2022
Director, Ten Percent Owner
Informative Buy
4.45M
$57.48M
IGM Biosciences
Apr 01, 2024
Director, Ten Percent Owner
Uninformative Buy
―
$30.53M
Atreca
Oct 23, 2023
Former 10% Owner
Informative Sell
109.90K
$228.78K
Zymeworks
―
Director
―
―
Prelude Therapeutics
Jan 29, 2021
Director, Ten Percent Owner
Informative Buy
133.33K
$38.68M
Spyre Therapeutics
―
Director
―
―
Talis Biomedical
Nov 19, 2021
Director, Ten Percent Owner
Informative Buy
218.00K
$64.43M
TScan Therapeutics
May 12, 2022
Director
Informative Buy
2.56M
$17.07M
Entrada Therapeutics Inc
Jun 06, 2022
Ten Percent Owner
Informative Buy
260.68K
$55.01M
DBV Technologies SA - American
Jun 13, 2022
Director, Ten Percent Owner
Uninformative Buy
―
$19.85M
Madrigal Pharmaceuticals
Dec 14, 2023
Director
Uninformative Buy
7.55M
$409.51M
vTv Therapeutics
Mar 07, 2024
Director
Uninformative Sell
―
$2.16M
Kymera Therapeutics
―
Director
―
―
Mirati Therapeutics
Nov 13, 2017
―
Informative Buy
2.20M
$2.13M
Neurogene
Oct 10, 2023
Director, Former 10% Owner
Uninformative Buy
―
$15.26M
Invitae
Mar 29, 2018
Ten Percent Owner
Informative Buy
5.00M
$83.09K
ACADIA Pharmaceuticals
Jun 05, 2023
Director, Ten Percent Owner
Uninformative Buy
―
$679.64M
Xoma
Jul 23, 2015
Former 10% owner
Informative Sell
11.99M
$2.20M
Genomic Health
Oct 03, 2019
―
Uninformative Buy
124.47K
$484.81M
Incyte
Apr 01, 2024
Director, Ten Percent Owner
Uninformative Buy
―
$1.79B
Seagen
Jun 02, 2023
―
Uninformative Buy
―
$9.84B
Synageva
―
―
―
―
List of latest transactions for each holding click on a transaction to see Baker Bros. Advisors Lp's performance on stock
You May Also Like
Baker Bros. Advisors Lp insider profile FAQ
What is the percentage of profitable transactions made by Baker Bros. Advisors Lp?
The percentage of profitable transactions made by Baker Bros. Advisors Lp is 56%.
What is the average return per transaction made by Baker Bros. Advisors Lp?
The average return per transaction made by Baker Bros. Advisors Lp is 29.10%.
What stocks does Baker Bros. Advisors Lp hold?
Baker Bros. Advisors Lp holds: BCRX, BLCM, BGNE, ACGN, ALXN, KNSA, HOOK, KOD, IGMS, BCEL, ZYME, PRLD, SYRE, TLIS, TCRX, TRDA, DBVT, MDGL, VTVT, KYMR, MRTX, NGNE, NVTAQ, ACAD, XOMA, GHDX, INCY, SGEN, GEVA stocks.
What was Baker Bros. Advisors Lp’s latest transaction?
Baker Bros. Advisors Lp latest transaction was an Uninformative Buy of ―.
What was Baker Bros. Advisors Lp's most profitable transaction?
Baker Bros. Advisors Lp’s most profitable transaction was an Informative Buy of NVTAQ stock on March 29, 2018. The return on the trade was 399.30%.
What is Baker Bros. Advisors Lp's role in BioCryst?
Baker Bros. Advisors Lp's role in BioCryst is Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.